Agoracom Blog Home

Posts Tagged ‘CSE’

American Creek Purchases Bear River Property in “Golden Triangle” of BC $AMK.ca

Posted by AGORACOM-JC at 9:35 AM on Wednesday, November 9th, 2016

Hublogolarge2_copy

  • Purchased the Bear River property located near Stewart in the “Golden Triangle” of northern British Columbia from Acme Resources Inc
  • 475 hectare Property is located approximately 8 km northeast of Stewart along highway 37A and is immediately adjacent to American Creek’s recently acquired Dunwell property package that includes the historic Dunwell mine

CARDSTON, ALBERTA–(Nov. 9, 2016) - American Creek Resources Ltd. (TSX VENTURE:AMK) (“American Creek”) is pleased to report that it has purchased the Bear River property (“the Property”) located near Stewart in the “Golden Triangle” of northern British Columbia from Acme Resources Inc.

The 475 hectare Property is located approximately 8 km northeast of Stewart along highway 37A and is immediately adjacent to American Creek’s recently acquired Dunwell property package that includes the historic Dunwell mine.

The Bear River property lies within the Portland Canal Fissure Zone which has hosted several high-grade lead/silver/gold deposits including the historic Portland and Dunwell mines. Several occurrences of gold and silver mineralization hosted in epithermal quartz veins and gold with massive sulphides in altered volcanics have been documented on the Property.

The principle target is the Hill Top Zone, covering an area 500m by 300m which consists mainly of silicified and pyritized volcanic, sedimentary and intrusive rocks. An IP survey on this zone identified an area of high chargeability confirming the presence of a large amount of sulphides in a silicified area. Soil sampling confirmed the IP results.

The contiguous land position including the Bear River, Silvershot and Dunwell property package now spans some 1,560 hectares covering a significant portion of the rich Portland Canal Fissure Zone which lies in “One of the most important mineral trends of northwestern British Columbia extending from near the town of Stewart north to the Treaty Glacier” – Nelson / Kyba, British Columbia Geological Survey, Ministry of Energy and Mines, 2014.

The Property is being purchased for the total price of 800,000 common shares of American Creek. The deemed price of the shares is $0.065 for total value of $52,000

The shares issued under this agreement will be subject to a statutory 4 month hold period. This agreement is subject to approval by the TSX Venture Exchange.

American Creek is a Canadian junior mineral exploration company focused on the acquisition, exploration and development of mineral deposits within the Province of British Columbia, Canada.

In addition to this new acquisition, the corporation has a portfolio of gold and silver properties in various regions of the province:

Information relating to the Corporation is available on its website at www.americancreek.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Kelvin Burton
403 752-4040
[email protected]
www.americancreek.com

Namaste Highlights Voting Results from Key US States and Grants Options $N.ca

Posted by AGORACOM-JC at 9:29 AM on Wednesday, November 9th, 2016

Nlogo

  • US states including California, Nevada, Massachusetts, and Maine voted to support the legalization of cannabis for recreational purposes
  • Post voting, a total of eight states have now legalized cannabis for recreational purposes, which represents upwards of 68 million people living in states where the recreational consumption of cannabis is legal

VANCOUVER, BRITISH COLUMBIA–(Nov. 9, 2016) – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(FRANKFURT:M5BQ) is pleased to report on the Company’s market position in the context of the recent voting results on the legalization of cannabis for recreational and medical purposes in US states. Specifically, of note, US states including California, Nevada, Massachusetts, and Maine voted to support the legalization of cannabis for recreational purposes. Post voting, a total of eight states have now legalized cannabis for recreational purposes, which represents upwards of 68 million people living in states where the recreational consumption of cannabis is legal. This represents approximately 21% of the total US population. Based on these voting results, it is anticipated additional US states will pursue legalization in future.

As a result of the acquisition of VaporSeller and URT1, Namaste is ideally positioned to capitalize on these developments in the US, where 74% of the Company’s customer base is located. This includes traffic originating from the state of California, the most populated state in the US and now one of the largest legalized cannabis markets in the world, where Namaste’s portals generated total site sessions of 76,829 for the months of September and October. It is anticipated that site traffic and sales from California and other states where voters supported legalization will increase in the foreseeable future.

Sean Dollinger, President and CEO of , comments: “The voting results that we have received this morning represent a historic event. At the beginning of 2016, we set forth with the objective of increasing our US presence and post completion of our first two acquisitions, we have ideally positioned ourselves to capitalize on deregulation events such as those that have just taken place. We will now focus our efforts on expanding our presence and offering in these key states.”

Option Grant

Namaste further announces that pursuant to the Company’s shareholder approved Stock Option Plan, the Company’s Board of Directors granted a total of 5,530,000 Incentive Stock Options (“Options”) to directors, officers, employees and consultants of the Company. 4,930,000 Options shall vest over a period of 2 years and 600,000 Options shall vest over a period of 1 year. All Options vest on a quarterly basis and have an exercise price of $0.35.

Select compensation includes:

  • Sean Dollinger, President and CEO – 1,500,000 Options and US$125,000 annual cash compensation; and 
  • Philip van den Burg, CFO – 1,200,000 Options and US$100,000 annual cash compensation.

About Namaste Technologies Inc.

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.vaporseller.com

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD-LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
[email protected]
www.namastetechnologies.com

 

Marijuana wins big on election night $MCOA.us $TBP.ca

Posted by AGORACOM-JC at 8:39 AM on Wednesday, November 9th, 2016


(Linda Davidson/The Washington Post)

  • On the medical side, voters in Florida, North Dakota and Arkansas have approved medical marijuana initiatives
  • separate measure in Montana that would loosen restrictions on an existing medical pot law was leading early Wednesday with only 30 percent of votes counted
  • Reformers were jubilant. “This represents a monumental victory for the marijuana reform movement,” said Ethan Nadelmann, executive director of the Drug Policy Alliance, in a statement. “With California’s leadership now, the end of marijuana prohibition nationally, and even internationally, is fast approaching.”

On the medical side, voters in Florida, North Dakota and Arkansas have approved medical marijuana initiatives. A separate measure in Montana that would loosen restrictions on an existing medical pot law was leading early Wednesday with only 30 percent of votes counted.

Reformers were jubilant. “This represents a monumental victory for the marijuana reform movement,” said Ethan Nadelmann, executive director of the Drug Policy Alliance, in a statement. “With California’s leadership now, the end of marijuana prohibition nationally, and even internationally, is fast approaching.”

How marijuana legalization in Washington, Colorado and Oregon is working out so far
Post)

California has long been seen as a bellwether by both supporters and opponents of marijuana reform. The state is home to about 12 percent of the U.S. population. Given the size of the state’s economy and the economic impact of the marijuana industry there, California’s adoption of legal marijuana could prompt federal authorities to rethink their decades-long prohibition on the use of marijuana.
In a recent interview with Bill Maher, President Obama said that passage of the legalization measures on Tuesday could make the current federal approach to the drug “untenable.”

Still, the likelihood of a Trump White House leaves a lot of uncertainty about the fate of marijuana measures in the next four years. Under Obama, federal authorities largely took a hands-off approach to state-level legalization efforts. But an incoming administration more skeptical of drug reform could easily reverse that approach.

“The prospect of Rudy Giuliani or Chris Christie as attorney general does not bode well,” the Drug Policy Alliance’s Nadelmann said in an interview. “There are various ways in which a hostile White House could trip things up.”

Still, Nadelmann pointed to the success of marijuana measures in the midst of an evident Republican wave as a sign that support for legalization now cuts deeply across party lines. And citing Trump’s often contradictory statements on marijuana and drug use in the past, Nadelmann added that “Donald Trump personally could probably go any which way on this.”

With today’s votes, legal marijuana is also making significant inroads in the Northeast. “Marijuana legalization has arrived on the East Coast,” said Tom Angell of the marijuana reform group Marijuana Majority in an email. “What Colorado and other states have already done is generating revenue, creating jobs and reducing crime, so it’s not surprising that voters in more places are eager to end prohibition.”

Opponents of legalization said they were disappointed by the outcomes. “We were outspent greatly in both California and Massachusetts, so this loss is disappointing, but not wholly unexpected,” said Kevin Sabet of the anti-legalization group Smart Approaches to Marijuana in a statement. “Despite having gained considerable ground in the last few weeks, the out-of-state interests determined to make money off of legalization put in too much money to overcome.”

Votes on medical marijuana in Florida and North Dakota were decisive. Florida’s Amendment 2 passed with 71 percent support, according to the Associated Press. In North Dakota, the AP reports that 64 percent of voters approving of the medical marijuana measure.

[One striking chart shows why pharma companies are fighting legal marijuana]

Two years ago, a medical marijuana measure in Florida earned 58 percent of the vote, just shy of the 60 percent threshold needed for passage. Then, as now, opposition to the measure was fueled by multimillion-dollar donations from Sheldon Adelson, the Las Vegas casino magnate and GOP donor. In 2014 Adelson spent $5.5 million to defeat the measure. This year he’s spent $1.5 million in Florida, and several million more to defeat recreational marijuana measures in other states.

“This is a major tipping point,” said Tom Angell of Florida’s vote. “With Florida’s decision, a majority of states in the U.S. now have laws allowing patients to find relief with medical marijuana, and these protections and programs are no longer concentrated in certain regions of the country like the West and Northeast.”

The victory in North Dakota is something of a surprise as no polling was done on the measure.

The Florida amendment has the potential to be one of the more permissive medical marijuana regimes in the nation. In addition to diseases like HIV, cancer and PTSD, the measure also allows doctors to recommend medical pot for “other debilitating medical conditions of the same kind or class as or comparable to those enumerated, and for which a physician believes that the medical use of marijuana would likely outweigh the potential health risks for a patient.” While the 2014 measure allowed doctors to prescribe marijuana for any illness they believed it would be useful for, the new measure requires they show the illness is severe — though the wording gives physicians considerable leeway in determining which conditions would meet those criteria.

The medical pot measure in North Dakota allows doctors to recommend the drug for a number of severe medical conditions.

With the passage of Amendment 2, Florida will become the first Southern state to enact a robust medical marijuana regime. Medical marijuana is already legal in 25 other states and the District.

Source: https://www.washingtonpost.com/news/wonk/wp/2016/11/08/medical-marijuana-sails-to-victory-in-florida/

INTERVIEW: Tetra Bio-Pharma Developing Pharma Derived From Cannabis and Other Medicinal Plants $TBP.ca

Posted by AGORACOM-JC at 11:41 AM on Tuesday, November 8th, 2016

Pharmaceutical Division – PhytoPain Pharma

  • Developing and commercialization of botanical based pharmaceuticals
  • Engaged in the development of medication to alleviate symptoms related to: Pain, Insomnia, anxiety disorder, in patients suffering from Cancer and other, chronic and terminal diseases

Recent Highlights

  • Signed a Supply Agreement with Access to Cannabis for Medical Purpose Regulations (“ACMPR”) licensed producer Aphria Inc.
  • For the supply of dried medical cannabis as an Active Pharmaceutical Ingredient (API) for PPP’s inhalation cannabis product PPP001
  • Acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa
  • Recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content

Hub On AGORACOM / Corporate Profile / Watch Interview

hempSMART.com is now live, products can be purchased, check it out! $MCOA.us

Posted by AGORACOM-JC at 6:24 PM on Monday, November 7th, 2016

hempSMART.com is now live, products can be purchased!

  • Formulated to promote brain health
  • Combines enhanced memory/cognitive function benefits with the additional benefits offered by CBD

Watch Our Recent Video

Explor Closes a First Tranche of a Maximum of $2 Million Private Placement in Flow-Through Shares $EXS.ca

Posted by AGORACOM-JC at 4:31 PM on Friday, November 4th, 2016

Exs_logo

  •  Announces the closing of a first tranche of a non-brokered private placement of a maximum of 23,529,412 flow-through common shares at a price of $0.085 each, for total gross proceeds of up to CDN $2,000,000
  • First tranche of the Private Placement closed today consists in the sale of 14,117,529 shares for an aggregate subscription of $1,199,990.

ROUYN-NORANDA, QUEBEC–(Nov. 4, 2016) – Explor Resources Inc. (TSX VENTURE:EXS)(OTCQX:EXSFF)(FRANKFURT:E1H1)(BERLIN:E1H1) (“Explor” or the Corporation) announces the closing of a first tranche of a non-brokered private placement of a maximum of 23,529,412 flow-through common shares at a price of $0.085 each, for total gross proceeds of up to CDN $2,000,000 (the “Private Placement“). The first tranche of the Private Placement closed today consists in the sale of 14,117,529 shares for an aggregate subscription of $1,199,990.

The net proceeds from the Private Placement will have to be incurred by the Corporation in exploration expenditures on mining properties located in the provinces of Québec and Ontario.

In connection with the Private Placement, the Corporation will pay to an arm’s length finder, finder’s fees representing a cash amount equal to 8% of the subscribed amount through the finder, and non-transferrable finder’s warrants entitling to purchase such number of common shares of the Corporation equal to 8% of the aggregate number of shares subscribed through the finder. These finder’s warrants will be exercisable at a price of $0.085 per common share, up to 24 months from the closing date.

The securities issued pursuant to the first closing of the Private Placement are subject to a hold period of four months and a day ending March 5, 2017. The Private Placement is subject to the final approval of the TSX Venture Exchange.

Explor Resources Inc. is a publicly listed company trading on the TSX Venture (EXS), on the OTCQX (EXSFF) and on the Frankfurt and Berlin Stock Exchanges (E1H1).

This press release was prepared by Explor. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the Policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.

About Explor Resources Inc.

Explor Resources Inc. is a Canadian-based natural resources company with mineral holdings in Ontario, Québec, Saskatchewan and New Brunswick. Explor is currently focused on exploration in the Abitibi Greenstone Belt. The belt is found in both provinces of Ontario and Québec with approximately 33% in Ontario and 67% in Québec. The Belt has produced in excess of 180,000,000 ounces of gold and 450,000,000 tonnes of cu-zn ore over the last 100 years. The Corporation was continued under the laws of Alberta in 1986 and has had its main office in Québec since 2006.

Explor Resources Flagship project is the Timmins Porcupine West (TPW) Project located in the Porcupine mining camp, in the Province of Ontario. Teck Resources Ltd. is currently conducting an exploration program as part of an earn-in on the TPW property. The TPW mineral resource (Press Release dated August 27, 2013) includes the following:

Open Pit Mineral Resources at a 0.30 g/t Au cut-off grade are as follows:
Indicated: 213,000 oz (4,283,000 tonnes at 1.55 g/t Au)
Inferred: 77,000 oz (1,140,000 tonnes at 2.09 g/t Au)
Underground Mineral Resources at a 1.70 g/t Au cut-off grade are as follows:
Indicated: 396,000 oz (4,420,000 tonnes at 2.79 g/t Au)
Inferred: 393,000 oz (5,185,000 tonnes at 2.36 g/t Au)

This document may contain forward-looking statements relating to Explor’s operations or to the environment in which it operates. Such statements are based on operations, estimates, forecasts and projections. They are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and may be beyond Explor’s control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements, including those set forth in other public filling. In addition, such statements relate to the date on which they are made. Consequently, undue reliance should not be placed on such forward-looking statements. Explor disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.

Christian Dupont, President
888-997-4630 or 819-797-4630
819-797-1870
www.explorresources.com
[email protected]

TRADE DATA!!! $MCOA.us +278% in Just 6 Trading Days

Posted by AGORACOM-JC at 4:53 PM on Thursday, November 3rd, 2016

15233_mcoa

MCOA: OTC

Marijuana Could Be The Big Winner On November 8th

  • Pot on the ballot in nine states, the big winner in next Tuesday’s election could be America’s legal cannabis industry.
  • By 2020, legal market sales are expected to surpass $22 billion.
  • For states struggling with budget shortfalls, that extra revenue would be clearly welcome.

MCOA Hub on AGORACOM / Corporate Profile / Watch Video

Marijuana Could Be The Big Winner On November 8th $MCOA.us

Posted by AGORACOM-JC at 12:33 PM on Thursday, November 3rd, 2016

  • Pot on the ballot in nine states, the big winner in next Tuesday’s election could be America’s legal cannabis industry.
  • By 2020, legal market sales are expected to surpass $22 billion.
  • For states struggling with budget shortfalls, that extra revenue would be clearly welcome.

MCOA Hub on AGORACOM / Corporate Profile / Watch Video

Namaste Expands Product Portfolio in Advance of US Elections $N.ca

Posted by AGORACOM-JC at 9:02 AM on Thursday, November 3rd, 2016

Nlogo

  • Company has secured new agreements with manufacturers of indoor growing equipment
  • Product lines will be added to Namaste’s e-commerce portals and complement the Company’s existing portfolio of vaporizers, pipes, papers and other accessories
  • New product portfolio also represents a further monetization of Namaste’s customer list of approximately 250 thousand names

VANCOUVER, BRITISH COLUMBIA–(Nov. 3, 2016) – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(FRANKFURT:M5BQ) is pleased to announce that the Company has secured new agreements with manufacturers of indoor growing equipment. These product lines will be added to Namaste’s e-commerce portals and complement the Company’s existing portfolio of vaporizers, pipes, papers and other accessories. This new product portfolio also represents a further monetization of Namaste’s customer list of approximately 250 thousand names.

US Elections

Currently, cannabis is legal for medical use in 25 states and recreational use in four states. Next week, the US will have three states voting on the legalization of medical use (Florida, Arkansas, and North Dakota) and five states voting on the legalization of recreational use of cannabis (California, Massachusetts, Arizona, Nevada, and Maine). Should all five states vote in favor of recreational marijuana, the US could have upwards of 75 million people living in states where the recreational consumption of cannabis will be legal. This represents approximately 23% of the total US population and is anticipated to advance the potential for legalization in additional states. In the US, support for the legalization of cannabis reached an all-time high of 57% in favor. Namaste’s product portfolio is ideally positioned to capitalize on these potential developments in the US.

Agreement Details

Namaste has entered into agreements with Gorilla Grow Tent Inc., SuperCloset Inc. and Kind LED Grow Lights, all leading manufacturers of the most advanced growing equipment available on the market. Namaste will initially market each of the manufacturers’ products in the US and Canada, and will receive wholesale rates on product sales. It is anticipated after the initial launch, Namaste will launch each of these brands into the twenty international markets Nasmaste currently serves.

Management Commentary

Sean Dollinger, President and CEO of Namaste, comments: “The markets for our current and new products are expanding considerably. With the acquisition of VaporSeller and URT1, we have given ourselves a substantial position in the US market which now represents 74% of our customer base. We view the upcoming election in the US as a key catalyst for our company and will continue to focus our efforts on expanding our brands in the US, which is the largest market for our products globally.”

About Gorilla Grow Tent Inc.

Gorilla Grow Tents are professionally designed grow tents that are ideal for experts and perfect for beginners and set the standard for quality and durability. Each grow tent is built with stable reinforced materials and are the strongest and safest materials available. Gorilla Grow tents have no plastic and feature a proprietary diamond reflection technology for best yield. Gorilla Grow Tents also feature a patent pending adjustable height extension kit that gives you the ability to increase your growing height from 7′ to 8′ or even 9′ tall.

About SuperCloset Inc.

Founded by Kip Anderson in 2002, SuperCloset, also known as SuperPonics, is accredited by the Better Business Bureau and maintains a perfect A+ rating, surpassing any other company in the hydroponics industry. SuperCloset is known as the leading manufacturer of Automated Superponics Systems and Grow Boxes in the world. Based in beautiful San Francisco, California, the company is in the perfect environment for combining innovative and imaginative ideologies with progressive methods of harvesting local, sustainable and organic products.

About Kind LED Grow Lights

Kind LED Grow Lights are the industry leader in indoor LED grow lights. Kind LED consulted with hundreds of professional hydroponic and soil growers to rigorously research and develop their cutting edge LED indoor grow light technology that has since revolutionized the indoor growing industry. Kind LED is widely considered the best indoor LED grow light on the market today. Kind LED Grow Lights are comprised of high powered 5 and/or 3 Watt Light Emitting Diodes featuring a proprietary intensified 12 band spectrum, including infrared and UV diodes designed for both vegetative and flowering stages of growth.

About Namaste Technologies Inc.

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 ecommerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.vaporseller.com

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors 5 discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
[email protected]
www.namastetechnologies.com

Tetra Bio-Pharma Enters Into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc. $TBP.ca

Posted by AGORACOM-JC at 8:36 AM on Thursday, November 3rd, 2016

Tbp_large

  • Signed a Supply Agreement with Access to Cannabis for Medical Purpose Regulations (“ACMPR”) licensed producer Aphria Inc.
  • For the supply of dried medical cannabis as an Active Pharmaceutical Ingredient (API) for PPP’s inhalation cannabis product PPP001

OTTAWA, ONTARIO–(Nov. 3, 2016) – Tetra Bio-Pharma Inc. (“TetraBio” or the “Company“) (CSE:TBP) through its subsidiary, PhytoPain Pharma Inc. (“PPP“), is pleased to announce that it has signed a Supply Agreement with Access to Cannabis for Medical Purpose Regulations (“ACMPR“) licensed producer Aphria Inc. (“Aphria“) (TSX VENTURE:APH)(OTCQB:APHQF) for the supply of dried medical cannabis as an Active Pharmaceutical Ingredient (API) for PPP’s inhalation cannabis product PPP001. PPP001 is a medical marijuana product that the company is developing as a prescription controlled drug for inhalation using a fully assembled titanium pipe.

Aphria is a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations.Under this supply agreement with Aphria, PPP shall pursue the development of a prescription controlled inhalation drug product of medical marijuana and seek marketing approval across the world either directly or indirectly through partnerships or licensing agreements. Aphria will be the exclusive supplier of this API to PPP for the development and commercialisation of PP001.

PPP is granted an exclusive, non-transferrable, royalty free, licence to use the API in the development of PPP001. The agreement defines a purchase price during the clinical development and a volume rebate once a target volume is reached.

Both Canadian and USA prescription drug regulations impose rigorous quality systems for the manufacturing of both the API and finished drug product. These requirements include conformance to pharmaceutical Good Manufacturing Practice regulations (“GMP“) as well as demonstrating the ability of the manufacturer to ensure lot-to-lot consistency in the quality and safety of the prescription drug.

Dr. Guy Chamberland, M.Sc., Ph.D., Chief Scientific Officer and Regulatory Affairs, PhytoPain Pharma Inc., commented, “We are very pleased and excited to be working with Aphria in the development of PPP001. Developing prescription botanical based pharmaceuticals requires a high quality GMP system and well-established product specifications to ensure consistent efficacy and ultimately protect the safety of patients. Based on our assessment of Aphria, we are confident that their high quality GMP medical cannabis production facility and impressive quality assurance team will meet or exceed the expectations of both the Canadian and USA prescription drug authorities.”

“With this agreement in place, PPP is now in a solid position to submit its Clinical Trial Application (CTA) for its planned Phase I trial in healthy volunteers. The company is also on track for submitting its Pre-IND Information Package for its upcoming meeting the US FDA,” stated Dr. Chamberland.

“Aphria is excited and proud to be an integral part of advancing the scientific research being led by Dr. Chamberland and the team at Tetra Bio-Pharma. Using our proprietary and high quality medical cannabis blend supported by high calibre research is exactly what professional healthcare practitioners require to gain the confidence to prescribe medical cannabis as a pharmaceutical,” said Vic Neufeld, Chief Executive Officer, Aphria Inc.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Neither the TSX Venture Exchange (the “Exchange”) nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
André Rancourt
Chief Executive Officer

Tetra Bio-Pharma Inc.
Ryan Brown
VP Business Development and Communications

Tetra Bio-Pharma Inc.
André Audet
Executive Chairman
(613) 421-8402

Aphria Inc.
Vic Neufeld
1-844-427-4742